Lux Capital manages over $5 billion in assets focused on founding, seed, early-stage, and growth investments at the intersection of technology and the sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high-growth sectors. Its investment team has built over 20 companies from scratch. Lux's investment strategy ensures portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.

Lux Capital

Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and other growth enterprises worldwide. They represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations, as well as the venture firms, private equity firms, and investment banks that finance and advise them. The firm's broad range of services and practice areas are focused on addressing the principal challenges faced by the management, boards of directors, shareholders, and in-house counsel of their clients.  The firm is nationally recognized for providing high-quality services to address the legal solutions required by its enterprise and financial institution clients. Their services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law, among other areas. Their distinguished international roster of clients span a wide variety of industries, including information technology, life sciences, energy and clean technology, media and entertainment, communications, retail, and financial services.

Wilson Sonsini Goodrich & Rosati

Alumni Ventures Group provides high-quality, diversified venture portfolios to individual investors who previously haven't had access to VC. It helps accredited alums from top entrepreneurial schools invest together in the ventures of fellow alums. The firm backs companies with an alumni connection and an institutional lead investor with expertise in the space. AVG also offers focused funds that allow any accredited investor access to a venture portfolio, diversified by type, sector, stage, and geography. Beth Obermiller, Michael Madden, and Mike Collins co-founded the firm in Manchester, New Hampshire in 2013.

Alumni Ventures

Quiet Capital is a technology investment firm.

Quiet Capital

VamosVentures is a venture capital fund that invests in Latinx and diverse founders leading early-stage tech-enabled companies in the United States across Health + Wellness, Future of Work, FinTech, and Sustainability.  VamosVentures seeks to generate financial returns and deliver meaningful impact through wealth creation, social mobility, and creative solutions. The fund will lead, co-lead, or participate in funding rounds.

VamosVentures

Early-stage venture firm backing electric founders with an uncontrollable passion for creating. The company has offices in San Francisco and New York.

Adapt Ventures

Floating Point is an early-stage venture capital firm. The company has offices in both Boston and New York.

Floating Point

Asymmetric Capital Partners (''Asymmetric'') is a venture capital firm investing in pre-seed and seed stage companies with a focus on B2B SaaS, marketplaces, digital health, and fintech. The firm was founded in 2021 by Rob Biederman and currently invests from its Fund I with $105 million in assets under management. Asymmetric seeks to partner with disruptive technology and internet companies by offering founders and limited partners transparent, research-driven, and operator-centric capital. The firm uses a thesis-driven approach to preemptively identify opportunities and back visionary leaders seeking to disrupt large markets. The firm’s team members are spread across San Francisco, New York, and Boston.

Asymmetric Capital Partners

Miga

Miga is a virtual cardiometabolic clinic that combines a character-driven, gamified app (akin to Duolingo) with full-stack clinical services (labs, devices, pharmacy, lifestyle) across obesity, hypertension, diabetes, and hyperlipidemia. Founded by Jarrad Aguirre, MD, and Dre Limberopoulos, Miga is building the future of cardiometabolic health.

<div>California-based remote patient monitoring startup Miga Health is developing a consumer app for managing heart health. The app will facilitate at-home blood pressure monitoring and analysis, virtual consultations, medication delivery, and lifestyle coaching. The app will also include other educational content and non-clinical features. The app will be available across multiple states but will have clinical services in select states. In the long term, the firm plans to accept insurance for its services.</div>

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

Miga Health

<div>
 
 California-based remote patient monitoring startup Miga Health is developing a consumer app for managing heart health. The app will facilitate at-home blood pressure monitoring and analysis, virtual consultations, medication delivery, and lifestyle coaching. The app will also include other educational content and non-clinical features. The app will be available across multiple states but will have clinical services in select states. In the long term, the firm plans to accept insurance for its services.
 
 
 
 
 Key customers and partnerships
 
 
 In 
 <a href="https://sp-edge.com/updates/21755">
 September 2023
 </a>
 , the company partnered with Sana, a provider of self-funded health insurance, to offer Miga's heart health program for obesity, hypertension, diabetes, and hyperlipidemia to over 25,000 Sana Benefits members across 10 states.
 
 
 
 
 Funding and financials
 
 
 The company&rsquo;s most recent investment took place in May 2022 amounting to USD 12 million raised in a seed funding round led by Quiet Capital. The funds were allocated to hire staff in order to build and launch their free consumer app, to include clinical care features focused on heart diseases within 2022.
 
</div>

<div>
 
 Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
 
 
 In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
 
 
 
</div>

Nice Healthcare

<div>
 
 Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications. 
 
 
 Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.
 
</div>

Amicomed

<div>
 
 Winston is a men&rsquo;s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients. 
 
 
 The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.
 
</div>

Winston

<div>
 
 Eko Health is a cardiopulmonary digital health company that aims to improve heart and lung care for patients using sensors and artificial intelligence. The company produces connected handheld digital stethoscopes with electrocardiogram functionality to detect heart rhythm abnormalities using artificial intelligence (AI) algorithms. In 2020, the company obtained 501(k) FDA clearance for multiple algorithms that help detect heart murmurs and atrial fibrillation, or AFib. These algorithms were used in 2022 to develop the Eko App, which pairs to the company's stethoscopes for report generation, information sharing and carrying out examinations. 
 
 
 The company operates on a fee per unit B2B2C model and a D2C model, where it provides its technology to medical practitioners or patients for diagnostic purposes.
 
 
 In February 2023, Eko 
 <a href="https://sp-edge.com/updates/16677">
 launched SENSORA
 </a>
 , a cardiac disease detection platform that combines the company&rsquo;s existing digital stethoscopes with a machine learning-based platform. The platform enables primary care physicians to detect structural murmurs and assess heart arrhythmias by using a database of heart sounds to compare and identify anomalies in a patient's heart beat. 
 
 
 In April 2024, Eko 
 <a href="https://sp-edge.com/updates/28111">
 obtained FDA 510(k) clearance
 </a>
 for its AI-aided cardiac tool, Eko Low Ejection Fraction Tool (ELEFT). The tool is designed to assist providers in early detection of low ejection fraction, a significant sign of heart failure.
 
 
 Funding and financials
 
 
 In March 2022, raised a further USD 30 million in an extension to its Series C round, which began November 2020. The total funds raised by the company stood at USD 126 million as of March. These funds have been allocated to support further commercialization efforts and develop new products for the company.
 
 
 
 
 
 
 
</div>

<div>
 
 Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
 
 
 The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care, wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
 
 
 Key Customers and partnerships
 
 
 Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
 
 
 Fundings and financials
 
 
 As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
 
 
 In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
 an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
 
 Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
 <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
 acquired by financial services company Sun Life Financial
 </a>
 for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
 
 
 
</div>

Dialogue

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

Real-time collection of patients’ health-related data using any remote patient monitoring device combined with general telemedicine services to reduce readmission rates. 


Miga Health

Telehealth

Key stats

Recent Updates

Miga partners with Sana Benefits to expand access to cardiovascular care

Miga partners with Sana Benefits to expand access to cardiovascular care

Company Brief

Funding

Investors

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless